![]() |
市场调查报告书
商品编码
1843282
皮肤移植的全球市场:移植片类型·产品类型·用途·终端用户·各地区 (~2034年)Global Skin Graft Market Research Report Information by Graft Type, by Product Type, by Application, by End User, and by Region Forecast till 2034 |
||||||
预计到 2034 年,全球植皮市场规模将达到 26.1958 亿美元,预测期内复合年增长率为 6.59%。植皮是一种医疗程序,从捐赠者部位获取健康皮肤,并将其移植到受伤或缺失的部位。该程序旨在促进烧伤、创伤和手术后的皮肤修復和再生。
全球植皮市场的发展受到糖尿病足溃疡和压疮等慢性伤口数量增加的驱动。糖尿病、肥胖症和血管疾病的增多推动了对先进治疗方法的需求。植皮在组织修復和感染控制方面非常有效。生物工程植皮和干细胞植皮等外科技术的进步已证明能够有效促进癒合,从而推动市场需求的长期成长和技术进步。
报告属性详细内容
美国仍然是领先的地区,得益于其强大的先进医疗设施、深厚的患者知识和数据,以及大量患有慢性伤口疾病的人群。同时,由于政府的优惠政策支援和伤口管理技术的进步,加拿大也正成为一个备受关注的潜力市场。
德国、英国和法国日益重视生物工程皮肤和移植材料,并确立了其在欧洲的领先地位。优惠的医疗政策和广泛的患者资讯为欧洲市场的长期可持续成长奠定了基础。
预计2024年,亚太市场规模将达到2.736亿美元,年复合成长率高达7.55%。政府对医疗产业的支持性政策和再生医学的进步正在进一步推动该地区的成长。
预计2024年,拉丁美洲市场规模将达到8,650万美元,年复合成长率为5.41%。巴西和墨西哥等国家正日益重视现代伤口照护方法,推动市场成长。该地区正在逐步采用先进的手术技术和生物工程皮肤移植材料。
预计2024年,中东和非洲市场规模将达到6,673万美元,复合年增长率为4.99%。市场扩张的动力来自整形外科手术的增加、医疗保健标准的提高以及医院基础设施投资的增加。海湾合作委员会国家,尤其是阿联酋和沙乌地阿拉伯,是主要贡献者,南非也正在成为一个值得关注的新兴市场。
本报告研究了全球皮肤移植市场,并提供了市场定义和概述、影响市场成长的各种因素分析、市场规模趋势和预测、各细分市场、地区和主要国家的细分情况、竞争格局以及主要公司的概况。
Global Skin Graft Market Research Report Information by Graft Type (Autograft, Allograft, Xenograft), by Product Type (Dermatome, Wound Debridement Device, Others), by Application (Pressure & Venous Ulcers, Diabetic Foot Ulcers, Burns, Surgical Wounds, Others), by End User (Hospitals, Ambulatory Surgery Centers, Specialty Centers), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) Forecast till 2034
Industry Overview
By 2034, the Global Skin Graft Market is expected to attain a valuation of USD 2,619.58 million, expanding at a steady CAGR of 6.59% during the forecast period. Skin grafting involves taking healthy skin from a donor site and transplanting it to an injured or defective area of the body. This medical procedure helps repair and regenerate skin after burns, trauma, or surgeries.
The global skin graft market is driven by the rising number of chronic wounds like diabetic foot ulcer and pressure ulcer diseases. The rise in diabetes, obesity, and vascular diseases have led to a considerable demand for advanced healing modalities. The skin grafts are quite effective in repairing tissue and combating infections. Advances in surgical technologies like bioengineering skin grafts and stem cell skin grafts have shown to be efficient in recovery and have led to an increase in longitudinal demand and technological advancement in the market.
Major Company Development
The major company development in Surtex Instruments is a global expansion of market presence through cooperation and tradeshows, the launch of the Infinex microsurgery series, and compliance with ISO 13485 Quality Management Standard. Surtex's continuous investment in the development of innovative products, sustainable practices, and innovation driven by customer needs has fortified the company's intent to provide reliable and cost-effective surgical solutions across diverse specialities around the world.
Major players in the global skin graft market are De Soutter Medical, B. Braun SE, Zimmer Biomet Holdings, Inc., Shaanxi Xingmao Industry Co., Ltd, Integra LifeSciences, AYGUN, Paramount Surgimed Ltd., Ribbel International Limited, Novo Surgical, Inc., and Surtex Instruments.
Report Attribute Details
Industry Segmentations
The United States remains a dominant region with a good base of advanced healthcare facilities, a thorough knowledge of the patients, and a large population group afflicted with chronic wound diseases. Canada is also showing good promise due to the friendly policies of the government ahead and advancements in techniques for wound management.
Germany, the UK, and France are becoming leaders in the presence of bioengineered skin and graft materials. The favourable health policy, coupled with increasing patient information, leads to a sound base for good longevity in growth in Europe.
Asia Pacific market value is expected to be USD 273.60 million in 2024 in the region and is likely to become the fastest growing section of the table at a healthy 7.55 percent CAGR. Government supported the health initiatives and advances in regenerative medicine also remains a growth area in the region.
The Latin America Skin Graft Market recorded a valuation of USD 86.50 million in 2024 and is projected to expand at a CAGR of 5.41%. Countries such as Brazil and Mexico are driving growth with an increasing focus on modern wound care practices. The region is gradually integrating advanced surgical techniques and bioengineered graft materials.
In 2024, the Middle East & Africa Skin Graft Market reached USD 66.73 million and is projected to grow at a CAGR of 4.99%. Market expansion is supported by the rise in reconstructive surgeries, improving healthcare standards, and growing investments in hospital infrastructure. GCC countries, particularly the UAE and Saudi Arabia, are key contributors, while South Africa is emerging as a notable market.